Bill
S 2374
Prohibits pre-approval or precertification of cancer treatments, tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.
New Jersey bill eliminates insurance pre-approval requirements for cancer treatments and drugs, enabling immediate access but potentially raising premiums and allowing denied claims post-treatment.